Granules India Reports Fourth Quarter And Annual Results

05 May 2026 CW Team

All monetary figures are in Rs million (mn). Granules India reported results for the fourth quarter and fiscal year ended 31 March 2026. Fourth quarter revenue from operations was Rs 14,706 mn, up 23 per cent year on year, with earnings before interest, tax, depreciation and amortisation of Rs 3,521 mn, up 40 per cent, and profit before tax before exceptional items at Rs 2,464 mn, up 48 per cent; net profit was Rs 2,016 mn, up 33 per cent.\n\nNorth America accounted for 72 per cent of fourth quarter revenue and Europe for 17 per cent. Finished dosages contributed 73 per cent, active pharmaceutical ingredients 13 per cent, pharmaceutical formulation intermediates 9 per cent and Peptides CDMO 5 per cent. Return on capital employed rose to 17.6 per cent in FY26 from 16.6 per cent, and net debt declined to Rs 4,021 mn, down Rs 3,040 mn year on year, leaving net debt to EBITDA at 0.34 times.\n\nOn a yearly basis, consolidated revenue was Rs 53,656 mn, up 20 per cent, with EBITDA of Rs 11,851 mn, up 25 per cent and an EBITDA margin of 22 per cent. Reported net profit for FY26 was Rs 5,950 mn, up 19 per cent year on year, and profit before tax before exceptional items was Rs 7,950 mn.\n\nThe chairman and managing director attributed the results to portfolio expansion, disciplined execution and progress on regulatory, compliance and sustainability initiatives, and noted improved earnings quality alongside advancement in complex generics and the Peptides CDMO platform. Granules India is a vertically integrated pharmaceutical company operating across active pharmaceutical ingredients, pharmaceutical formulation intermediates, finished dosages and Peptides CDMO, and serves more than 300 customers in over 80 countries. The group operates 10 manufacturing facilities, including 7 in India, 2 in the United States and 1 in Switzerland, and holds approvals from multiple regulators.

Products

07 Jul 2026

EUROBOND Expands NABL Accreditation to 51 Testing Parameters

EUROBOND, the flagship brand of Euro Panel Products, has expanded the National Accreditation Board for Testing and Calibration Laboratories (NABL) accreditation of its in-house laboratory from 16 to 51 mechanical and chemical testing parameters, making it the only Indian aluminium composite panel (ACP) manufacturer with accreditation covering such an extensive testing scope.The expanded accreditation enables the company to independently test coils, coatings, cores, aluminium composite panels (ACP) and metal composite panels (MCP) in accordance with international standards, including IS, ASTM, ..

Dubai Property Sales Rise as Rental Activity Hits Record High

Dubai's real estate market recorded its highest-ever monthly rental activity in June, while property sales rose sharply in both value and volume, reflecting sustained demand across the emirate's residential and commercial sectors.According to a market analysis by fäm Properties based on DXBinteract data, 40,022 rental contracts were registered during the month, the highest monthly total on record. New rental contracts increased 48.6 per cent year on year to 19,245, while renewals rose 28.5 per cent to 20,777.Property sales reached 13,933 transactions worth AED33.2 billion in June, representin..

Isprava Partners Courtside to Launch Luxury Padel Experience

Luxury home developer Isprava has partnered with Courtside, Mumbai's first padel social club, to launch The Isprava Court, integrating its design-led lifestyle proposition with one of the city's emerging sporting destinations.Located on the rooftop of Atria Mall in Worli, Courtside spans 20,000 sq ft and combines padel, wellness, hospitality and community experiences. Since opening in February 2026, the venue has positioned itself as a social hub for sports and lifestyle enthusiasts.The Isprava Court features curated brand elements, including bespoke court branding, branded nets, towels and ac..